Treatment of Moderate to Severe Facial Acne Vulgaris
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Randomized, multi-center, double-blind, placebo-controlled 12-week study to assess the safety
and efficacy of 3 doses of an oral formulation of Doxycycline oral tablets using the
Investigator's Global Assessment (IGA) score and the absolute change from baseline in
inflammatory lesion count in patients with moderate to severe facial acne vulgaris.
Additionally, the absolute change from baseline in non-inflammatory and total lesions of the
active study medication to placebo will be evaluated.